Mesoblast Limited
IPOPublic · Melbourne, Australia · Founded 2004 · $21.6M raised
- Headquarters
- Melbourne
- Employees
- 201–500
- Founded
- 2004
- Business Model
- B2B
- Website
- mesoblast.com
- Total Funding
- $21.6M
- Last Round
- $21.6M Growth EquityJan 2012
- Rounds
- 1
- Type
- Public
About
Mesoblast is a clinical-stage biopharmaceutical company developing allogeneic cellular medicines using its proprietary mesenchymal precursor cell technology platform for severe inflammatory conditions.
Summary
Mesoblast Limited is a Biotech company based in Melbourne, Australia, founded in 2004. It has raised $21.6M in total across 1 round, most recently a $21.6M Growth Equity round in Jan 2012.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2018
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...